| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 08/11/2009 | US7572796 excitatory amino acid antagonists for treating neurodegenerative diseases as cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, cerebral ischaemia, infarction, psychoses; 6-{3-[4-(4-fluorobenzyl)-1-piperidyl]propyl}-1H-indole-3-carbonitrile |
| 08/11/2009 | US7572793 Tau protein kinase 1 inhibitors; treatment for neurodegenerative disorders; Alzheimer's Disease, Parkinson's disease, Pick's Disease, vision defects; antiischemic, antidiabetic, anticarcinogenic, antitumor agents, antidepressants |
| 08/11/2009 | US7572786 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 08/11/2009 | CA2482551C 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists |
| 08/06/2009 | WO2009096609A1 Thiazole derivative and use thereof as vap-1 inhibitor |
| 08/06/2009 | WO2009096555A1 Method for producing compound having deuterated aromatic ring or heterocyclic ring |
| 08/06/2009 | WO2009096039A1 {2-(4-hydroxyphenoxy)propionyl}thiocarbazinic acid ester and process for producing the same |
| 08/06/2009 | WO2009095399A2 Pyrazine derivatives and their use as protein kinase inhbitors |
| 08/06/2009 | WO2009095394A1 Diazepanes as histamine h3 receptor antagonists |
| 08/06/2009 | WO2009095377A1 Spiro compounds as npy y5 receptor antagonists |
| 08/06/2009 | WO2009095324A1 Novel n-(2-amino-phenyl)-amide derivatives |
| 08/06/2009 | WO2009094845A1 5-(3-heteroaromatic ring substituted phenyl) tetrazole compounds and their uses for anti-hiv/aids |
| 08/06/2009 | WO2009054952A3 Small molecule inhibitors of parp activity |
| 08/06/2009 | US20090198052 Method for preparing optically active piperidine compounds |
| 08/06/2009 | US20090197925 O-cyclopropyl-carboxanilides and their use |
| 08/06/2009 | US20090197897 Novel Oxadiazole Derivatives and Their Use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors |
| 08/06/2009 | US20090197887 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
| 08/06/2009 | US20090197883 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use |
| 08/06/2009 | US20090197879 Vanilloid receptor ligands and their use in treatments |
| 08/06/2009 | US20090197877 Antibacterial Compositions |
| 08/06/2009 | US20090197875 Aryl-isoxazolo-4-yl-oxadiazole derivatives |
| 08/06/2009 | US20090197870 Pharmaceutical Compositions |
| 08/06/2009 | US20090197862 2-aminopyridine kinase inhibitors |
| 08/06/2009 | US20090197795 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/06/2009 | CA2713553A1 Pyrazine derivatives and their use as protein kinase inhibitors |
| 08/06/2009 | CA2712962A1 Thiazole derivative and use thereof as vap-1 inhibitor |
| 08/06/2009 | CA2711995A1 Novel n-(2-amino-phenyl)-amide derivatives |
| 08/05/2009 | EP2085394A2 Metronidazole derivatives as antiparasitic agents |
| 08/05/2009 | EP2085389A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2084165A1 Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate |
| 08/05/2009 | EP2084156A1 Polymorphs of 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrobromide and processes for preparation thereof |
| 08/05/2009 | EP2084155A1 Thiazole derivatives as kinase inhibitors |
| 08/05/2009 | EP2084151A1 Substituted dihydropyrazolones for treating cardiovascular and haematological diseases |
| 08/05/2009 | EP2084148A1 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives |
| 08/05/2009 | EP2084146A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/05/2009 | EP2084140A1 Arginine derivatives with np-i antagonistic activity |
| 08/05/2009 | EP2029559B1 Aryl-4-ethynyl-isoxazole derivatives |
| 08/05/2009 | EP1984354B1 Pesticides containing a bicyclic bisamide structure |
| 08/05/2009 | EP1924560B1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 08/05/2009 | EP1877398B1 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors |
| 08/05/2009 | EP1781606B1 Azetidine derivatives as ccr-3 receptor antagonists |
| 08/05/2009 | EP1742707A4 Treatment of cns disorders using cns target modulators |
| 08/05/2009 | EP1699454B1 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 08/05/2009 | EP1631292B1 4-anilino-quinazoline derivatives as antiproliferative agents |
| 08/05/2009 | EP1501797B1 3-(substituted amino)-1h-indole-2-carboxylic acid ester and 3-(substituted amino)-benzo[b]thiophene-2-carboxylic acid ester derivatives as interleukin-4 gene expression inhibitors |
| 08/05/2009 | EP1496052B1 Novel aminobenzamide derivative |
| 08/05/2009 | EP1475370B1 Optically active azole derivative and process for producing the same |
| 08/05/2009 | EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine |
| 08/05/2009 | EP1445253B1 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof |
| 08/05/2009 | EP1430040B1 Benzothiazepine derivatives |
| 08/05/2009 | EP1401825B1 Thiophene derivatives as antiviral agents for flavivirus infection |
| 08/05/2009 | EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor |
| 08/05/2009 | EP1296974B1 2-cyanopyrrolidine derivatives and their use as medicaments |
| 08/05/2009 | CN101501031A Oxazolidone derivatives as pr modulators |
| 08/05/2009 | CN101501028A 2-(heterocyclylbenzyl)-pyridazinonderivate |
| 08/05/2009 | CN101501023A Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents |
| 08/05/2009 | CN101501009A CGRP receptor antagonists |
| 08/05/2009 | CN101500994A 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments |
| 08/05/2009 | CN101497610A Dithiazole ethylene compound containing 2,1,3-diazosulfide unit |
| 08/05/2009 | CN101497602A Anthranilic acid compound and use thereof |
| 08/05/2009 | CN100522954C Kappa-opioid receptor agonist composed of 2-phenylbenzothiazoline derivative |
| 08/05/2009 | CN100522945C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522166C (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
| 08/05/2009 | CN100522161C (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor |
| 08/04/2009 | US7569695 Cyanine dyes substituted by electrophilic groups and/or nucleophilic groups including merocyanine, methine, oxazoline, oxonol, selenazole fluorescent, imidazoline, quinoline, indole, reactive and cationic dyes; labeling reagents for proteins and nucleic acids; genetic probes; amplification; hybridization |
| 08/04/2009 | US7569689 Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| 08/04/2009 | US7569688 Propane-1, 3-dione derivative |
| 08/04/2009 | US7569678 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 08/04/2009 | US7569596 e.g. N1-[(E)-1-(4-fluorophenyl)methylidene]-4-(1,3-thiazol-2-yl)-1H-1,2-imidazolediamine; anticarcinogenic agent; sid effect reduction |
| 08/04/2009 | US7569592 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 08/04/2009 | US7569591 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals |
| 08/04/2009 | US7569573 Nucleobase substituted with a 2-hydroxy-4-oxobut-2-enoic acid or ester or a 1-hydroxy-3-oxopropenephosphonic acid or ester, e.g., Methyl 4-(1,3-dibenzyl-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-5-yl)-2-hydroxy-4-oxobut-2-enoate |
| 08/04/2009 | US7569566 Inhibitors of tyrosine kinases |
| 08/04/2009 | US7569337 Labeling brain tissues in vivo or in vitro; 3-Benzothiazol-2-yl-7-[4-(2-fluoro-ethyl)-piperazin-1-yl]-chromen-2-one; diagnosis, monitoring the effectiveness of a therapeutic treatment and detecting histopathological hallmarks of Alzheimer's disease |
| 07/30/2009 | WO2009094445A2 Fungicidal hetercyclic compounds |
| 07/30/2009 | WO2009094442A2 5-fluoro pyrimidine derivatives as fungicides |
| 07/30/2009 | WO2009094407A2 Fungicidal amides |
| 07/30/2009 | WO2009094224A1 Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors |
| 07/30/2009 | WO2009094028A1 Aldh-2 inhibitors in the treatment of addiction |
| 07/30/2009 | WO2009093049A1 Fused pyridines active as inhibitors of c-met |
| 07/30/2009 | WO2009092432A1 Beta-amino acid derivatives for treatment of diabetes |
| 07/30/2009 | WO2009053737A3 Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders |
| 07/30/2009 | WO2009050595A3 An improved process for preparing a 2,4-thiazolidinedione derivative |
| 07/30/2009 | WO2009006404A3 Heterocyclic compounds useful as raf kinase inhibitors |
| 07/30/2009 | WO2008103613A3 Hydroxylamine compounds and methods of their use |
| 07/30/2009 | US20090192307 antiinflammatory agents; 1-[5-tert-butyl-3-(1,1-dioxo-1 lambda 6-[1,2,5]thiadiazepane-5-carbonyl)thiophen-2-yl]-3-[4-(pyridin-4-yloxy)phenyl]urea; enzyme inhibitors |
| 07/30/2009 | US20090192204 N-(2-thiazolyl)-amide derivatives as gsk-3 inhibitors |
| 07/30/2009 | US20090192197 Antibiotics with improved solubility, lower toxicity; potent antibacterial activity; includes Torezolid phosphate |
| 07/30/2009 | US20090192196 Fungicide hydroximoyl-tetrazole derivatives |
| 07/30/2009 | US20090192186 Biaryl substituted azabicyclic alkane derivatives |
| 07/30/2009 | US20090192179 Chroman derivatives |
| 07/30/2009 | US20090192171 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors |
| 07/30/2009 | US20090192139 Calcitonin gene-related peptide (CGRP) receptor antagonists such as N-[1-(2,3-Difluorobenzyl)-5-oxo-4-(2,22-trifluoroethyl)-1,4-diazepan-6-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide, used for treating headaches |
| 07/30/2009 | DE102007057718A1 New heteroaryl-substituted piperidine compounds are protease-activated receptor antagonists useful for the treatment and/or prophylaxis of e.g. cardiovascular diseases, thromboembolic diseases, tumors, stroke, hypertension and asthma |
| 07/30/2009 | CA2712998A1 Beta-amino acid derivatives for treatment of diabetes |
| 07/30/2009 | CA2712791A1 Fused pyridines active as inhibitors of c-met |
| 07/30/2009 | CA2712777A1 5-fluoro pyrimidine derivatives as fungicides |
| 07/30/2009 | CA2712750A1 Aldh-2 inhibitors in the treatment of addiction |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |